Evidence map›Paper›PMID 20304923›Full record

ArticleThe Journal of biological chemistry2010

The signal peptide of the IgE receptor alpha-chain prevents surface expression of an immunoreceptor tyrosine-based activation motif-free receptor pool.

Barbara Platzer, Edda Fiebiger

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Immunoglobulin E receptor signaling and asthma.The Journal of biological chemistry · 2011
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Barbara PlatzerDepartment of Medicine, Division of Gastroenterology and Nutrition, Children's Hospital Boston, Boston, Massachusetts 02115.
Edda FiebigerDepartment of Medicine, Division of Gastroenterology and Nutrition, Children's Hospital Boston, Boston, Massachusetts 02115. Electronic address: edda.fiebiger@childrens.harvard.edu.
Boston Children's Hospital · US

Funding

Studies of Fc-epsilon-RI as an antigen presentation structure at mucosal surfacesR01AI075037 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI FIEBIGER, ELISABETH EDDA · 2009 to 2013
$2.0M
Studies on Fc-epsilon-RI as an antigen presentation structure at mucosal surfacesR56AI075037 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI FIEBIGER, ELISABETH EDDA · 2008 to 2008
$423k
Studies on the role of FcERI-mediated DC activation in the gastrointestinal tractF32DK081256 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI PLATZER, BARBARA · 2008 to 2010
$121k
NIAID NIH HHS R01 AI075037NIAID NIH HHS R01AI075037NIAID NIH HHS R56 AI075037NIAID NIH HHS R56AI075037NIDDK NIH HHS DK081256NIDDK NIH HHS F32 DK081256
6 · The paper itself

Abstract

The high affinity receptor for IgE, Fc epsilon receptor I (FcepsilonRI), is an activating immune receptor and key regulator of allergy. Antigen-mediated cross-linking of IgE-loaded FcepsilonRI alpha-chains induces cell activation via immunoreceptor tyrosine-based activation motifs in associated signaling subunits, such as FcepsilonRI gamma-chains. Here we show that the human FcepsilonRI alpha-chain can efficiently reach the cell surface by itself as an IgE-binding receptor in the absence of associated signaling subunits when the endogenous signal peptide is swapped for that of murine major histocompatibility complex class-I H2-K(b). This single-chain isoform of FcepsilonRI exited the endoplasmic reticulum (ER), trafficked to the Golgi and, subsequently, trafficked to the cell surface. Mutational analysis showed that the signal peptide regulates surface expression in concert with other described ER retention signals of FcepsilonRI-alpha. Once the FcepsilonRI alpha-chain reached the cell surface by itself, it formed a ligand-binding receptor that stabilized upon IgE contact. Independently of the FcepsilonRI gamma-chain, this single-chain FcepsilonRI was internalized after receptor cross-linking and trafficked into a LAMP-1-positive lysosomal compartment like multimeric FcepsilonRI. These data suggest that the single-chain isoform is capable of shuttling IgE-antigen complexes into antigen loading compartments, which plays an important physiologic role in the initiation of immune responses toward allergens. We propose that, in addition to cytosolic and transmembrane ER retention signals, the FcepsilonRI alpha-chain signal peptide contains a negative regulatory signal that prevents expression of an immunoreceptor tyrosine-based activation motif-free IgE receptor pool, which would fail to induce cell activation.

Indexed as

Protein Sorting SignalsAmino Acid MotifsAmino Acid SequenceBase SequenceCell LineCell MembraneDNA PrimersEndoplasmic ReticulumFlow CytometryGolgi ApparatusHumansMicroscopy, FluorescenceMolecular Sequence DataProtein TransportReceptors, IgEReverse Transcriptase Polymerase Chain ReactionDNA PrimersProtein Sorting SignalsReceptors, IgETyrosine

Identifiers

PMID20304923
PMCPMC2865261
OpenAlexW2072263885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.